Professional Documents
Culture Documents
CYTOPATHOLOGY
2012
1) Lung fine needle aspiration; immunoreaction of cytokeratin 20 in colorectal cancer
2) Identification of lung carcinoma on aspirate
3) Acute leukemia; cerebrospinal fluid
4) Warthin's tumor; common bilateral benign tumor of the parotid gland
5) Cervicovaginal specimen; diagnose low grade squamous intraepithelial lesion
6) Identification; squamous cell carcinoma
7) Neck nodule; diagnose epidermal inclusion cyst from Papanicolaou stain
8) Merkel cell carcinoma
9) Deleted
10) Plasma cell neoplasm
11) Tubal metaplasia
12) Recognition of signet ring carcinoma in a body fluid
13) Pancreatic lesion smear; interpret reactive/reparative epithelium
14) Fine needle aspiration technique for a superficial lesion
15) CLIA '88 regulations; review of prior years normal cytology cases
16) Ovarian adenocarcinoma detected on Papanicolaou smear
17) Identification of Cryptococcus
18) Cytology fine needle aspirate; molecular markers of neuroblastoma
19) Bronchioloalveolar carcinoma; identification
20) Cervical smear; identify high grade squamous intraepithelial lesion
21) Fine needle aspiration; parotid mass; interpret pleomorphic adenoma
22) Invasive ductal carcinoma; identification from fine needle aspirate of breast
23) Recognition of malignant rhabdoid tumors
24) High-grade urothelial carcinoma; diagnose in urine
25) Most common chromosome aberrations associated with high grade urothelial carcinoma
26) Ovarian papillary serous carcinoma; identification
27) Large B-cell lymphoma and lymphoglandular body detection
28) Cerebrospinal fluid plasma cells; multiple sclerosis
29) Cervical smear; benign cellular changes/Trichomonas infection
30) Cytomegalovirus; identification
31) Metastatic colon adenocarcinoma; identification from fine needle aspiration
32) Metastatic adenocarcinoma in cerebrospinal fluid
33) Small cell carcinoma; identify cells in bronchial brushing
34) Recognition Hodgkin lymphoma
35) Urine; diagnose polyomavirus
36) Craniopharyngioma; diagnose
37) Esophageal brushing; diagnose adenocarcinoma
38) Fine needle aspirate from liver mass; diagnose hepatocellular carcinoma
AUTOPSY/FORENSIC PATHOLOGY
2012
45) Recognize mummification of hand/fingers
46) Distribution of burns; highly characteristic for inflicted scalding injuries
47) Recognize subacute myocardial infarct microscopically
48) Identification and characterization of pleural plaques
49) Gross myocardial infarct; determine age
50) Recognize cerebellar vermis atrophy related to chronic alcoholism
51) Risk factors for choking
52) Cause of death in automobile collision
53) Recognize a congenital umbilical hernia
54) Stippling around gunshot wound
55) Hypothermia; identification
56) Anthropophagy
57) Identification of hepatic hemangiomas
58) Petechial hemorrhages
59) Recognize livor mortis
60) Recognize seat-belt injuries in driver involved in motor vehicle collision
61) Recognize acid fast bacilli (AFB) stain and mycobacteria
62) Vitreous fluid; hyperglycemia
63) Cocaine; metabolite
64) Identify a suicidal incised wound; hesitation marks
65) Death is due to displacement of oxygen by helium
66) Cardiac valve; mitral valve prolapse
67) Identify epidural hemorrhage
68) Recognize ruptured cerebral artery aneurysm
69) Identify cerebral contusion from fixed brain
70) Recognition of horseshoe kidney
71) Violent deaths, unexpected death; report to Medical Examiner/Coroners Office
72) Commotio cordis; definition
73) Recognize gross and microscopic renal angiomyolipoma
74) Identify gunshot entrance wound; distant range-of-fire
75) Autopsy technique for visualization of esophageal varices
76) Exsanguination; mechanism of death
77) Deleted
78) Define adipocere
79) Recognize bone metastasis in spinal column
80) Recognize peritonitis
2013
44) Hyoid bone fracture
45) Postmortem heat-related epidural hemorrhage
46) Depressed oval skull fracture consistent with a hammer
47) Autosomal dominant (adult) polycystic kidney disease
48) Subepicardial fibrosis of the inferolateral wall; Duchenne muscular dystrophy
49) Electrocution with electrical burns of fingers
50) Identify skin marbling
51) Aortic laceration in motor vehicle collision
52) Air embolism technique
53) Sudden unexplained death in infancy
54) Identify patent ductus arteriosus; 1-month-old child
55) Identification of caf-au-lait spots and neurofibromas inneurofibromatosis
56) Vitreous electrolyte pattern in dehydration
57) Vitreous fluid; hyperglycemia
58) Identification of remote tracheostomy site
59) Postmortem insect bites
60) Identification; incised wounds of the skin
61) Death certification in post-operative pneumonia
62) Anomalous origin of the left coronary artery from the right sinus of Valsalva
63) Organization responsible for providing inspection and accreditation of offices
64) Identify cerebral contusion from fixed brain
65) Recognize dilated cardiomyopathy
66) Caseating apical lesion of secondary pulmonary tuberculosis
67) Recognize carbon monoxide-induced color change in brain
68) Displacement of oxygen by helium gas
69) Recognize prostatic hyperplasia
70) Papaverine; injected into veins prior to postmortem procurement
71) Early post mortem period; urea and creatinine concentrations
72) Definition of mechanism of death
73) Hesitation marks in suicides
74) Recognize fat necrosis grossly
75) Define adipocere
76) Patau syndrome (trisomy 13); identify polydactyly
77) Recognize the importance of scene investigation in infant deaths
78) Approximate the range-of-fire from gunshot wound
79) Cocaethylene; cocaine and ethanol administration
2014
42) Postmortem anal dilatation; pediatric autopsy
43) Identification of patent ductus arteriosus
44) Recognize histologic appearance of a contact gunshot wound
45) Recognize adrenal cortical adenoma
46) Chronic Wernicke's encephalopathy
47) Biochemistry of rigor mortis
SURGICAL PATHOLOGY
2012
81) Recognition of eosinophilic esophagitis
82) Collapsing variant of FSGS; HIV infection
83) Vacuolar interface change; lupus erythematosus, erythema multiforme
84) Nonspecific interstitial pneumonia; characteristics
85) Anaplasia in a nephroblastoma (Wilms tumor); a suboptimal response to chemotherapy
86) Recognition of normal colonic mucosa
87) Identify chondroblastoma
88) Identification of cardiac Quilty lesions
89) Odontogenic keratocyst (keratocystic odontogenic tumor); identification
90) Pseudoepitheliomatous hyperplasia; granular cell tumor in the oral cavity
91) Identification of dysgerminoma
92) Allergic contact dermatitis; recognition of spongiosis
93) Colonoscopy biopsy; ulcerative colitis
94) Metastatic carcinoma, myelophthisic anemia
95) Parathyroid hormone levels; parathyroid adenoma
96) Distinct fibrils; characteristic of amyloidosis
97) Spontaneous primary (idiopathic) pneumothorax; reactive eosinophilic pleuritis
2014
78)
79)
80)
81)
82)
83)
84)
85)
86)
87)
88)
89)
90)
91)
92)
93)
94)
95)
96)
97)
98)
99)
100)
101)
102)
103)
104)
105)
106)
107)
108)
109)
110)
111)
112)
113)
114)
115)
116)
117)
118)
119)
120)
121)
122)
123)
124)
125)
126)
127)
128)
129)
130)
131)
132)
133)
134)
135)
136)
137)
138)
139)
140)
141)
142)
143)
144)
145)
146)
147)
148)
149)
150)
151)
152)
2015
80) Dissecting aortic aneurysm; characteristics
81) Hepatic mass, CD 34 stain; epithelioid hemangioendothelioma
82) Inhalation rabies infection from bat infested caves
83) Dermatopathology, inflammatory
84) Knowledge of main type of cell participating in cardiac transplant rejection
85) Nested variant of urothelial carcinoma infiltrating muscularis propria
86) Classification of smooth muscle tumors of the uterus
87) Serous cystadenoma; characteristics
88) Gardner syndrome; identify osteoma
89) Palate mass; chordoma
90) Small cell carcinoma
91) Characteristics of uterine serous carcinomas
CP RISE 2012-2015
CLINICAL CHEMISTRY
2012
155) Methanol ingestion; serum osmole gap
156) Acute rhabdomyolysis; diagnostic chemistry tests
157) Hereditary angioedema; C4
158) Turnaround time
159) Heroin and codeine; morphine metabolite
160) Receiver operating characteristic (ROC) curves
161) Acute intermittent porphyria
162) Toxic metabolite of cocaine and alcohol co-use
163) Lead poisoning in children; venous whole blood
164) Mixed cryoglobulins
165) Methanol ingestion; formate formation
166) X-linked agammaglobulinemia; immune deficiency
167) Transthyretin; nutritional status
168) Sulfonylurea; type II diabetes therapy; insulin testing
169) Major intracellular cation; potassium
170) Drug monitoring for oxycodone
171) Sensitive and specific test for celiac disease; serum IgA anti-tissue transglutaminase
172) Desirable lipid concentrations; outcomes and consensus opinion; e.g., NCEP-ATPIII
173) Allergic bronchopulmonary mycosis; total IgE and IgE against Aspergillus
174) Delta checks; identify mislabels and major isolated instrument errors
175) Plasma free metanephrines; pheochromocytoma
176) Functional sensitivity of an assay; interpretation of results
177) Friedewald calculation
178) Rheumatoid arthritis; antibodies to cyclic citrullinated peptides
179) Knowledge of abnormal laboratory values in acid-base and electrolyte disorders
180) Protein content in lipid fractions
181) Antimitochondrial antibodies; primary biliary cirrhosis
182) Multi-drug resistance gene (MDR1) and cytochrome P450 3A; tacrolimus
183) Repeated fist clenching during the tourniquet phase of hlebotomy; affect potassium level
184) Clinical test sensitivity; calculate
185) Comparison of methods; systematic error
186) Negative fetal fibronectin result; associated with delivering within a week
187) Antigen excess
188) Glomerular filtration rate; age, sex, race, serum creatinine
189) Calcium homeostasis disorders and nutritional deficiencies
190) Cushing syndrome; ACTH-secreting pituitary adenoma
191) Hair; drug abuse detection
192) Bence Jones proteinuria
2014
153)
154)
155)
156)
157)
158)
159)
160)
161)
162)
163)
164)
165)
166)
167)
168)
169)
170)
171)
172)
173)
174)
175)
176)
177)
178)
179)
180)
181)
182)
183)
184)
185)
186)
187)
188)
189)
190)
191)
192)
2015
152) Lamellar body counts; fetal lung maturity
HEMATOLOGY
2012
195) Identification; Babesia microti
199)
200)
201)
202)
203)
204)
205)
206)
207)
208)
209)
210)
211)
212)
213)
214)
215)
216)
217)
218)
219)
220)
221)
222)
223)
224)
225)
226)
227)
228)
229)
230)
231)
232)
233)
2015
192) Flow cytometry; lymphocyte light scatter techniques
193) Neuroblastoma: bone marrow aspirate smear morphology and MYCN amplification as a prognostic
marker
194) Antimalarial drug therapy; adverse effect
195) Prothrombin complex concentrates; reverse anticoagulant effect
196) Hemoglobin S/+-thalassemia
197) Drying artifact and effect on red blood cell morphology
198) Increased sensitivity to low dose (0.5 mg/mL) ristocetin in type 2B von Willebrand Disease
MICROBIOLOGY
2012
235) Penicillium marneffei; etiology and identification
236) Cryptococcus neoformans, cornmeal agar
237) D test; inducible resistance to clindamycin
238) Microscopic morphology of Plasmodium falciparum gametocytes
239) Detection of Clostridium difficile
240) Virus detection; rapid shell vial culture
241) Streptococcus pyogenes cellulitis and soft tissue infection; clinical characteristics
242) Modified Hodge test for Klebsiella pneumoniae carbapenemase
248)
249)
250)
251)
252)
253)
254)
255)
256)
257)
258)
259)
260)
261)
262)
263)
264)
265)
266)
267)
268)
269)
270)
271)
272)
273)
2015
232) Laboratory detection of West Nile virus; serology vs. polymerase chain reaction
233) M. gordonae; contaminant from tap water
234) Cysticercosis; Taenia solium ova
235) Acanthamoeba species; preferred culture medium
236) Mycobacterium abscessus; growth and Gram stain characteristics
237) Examination of auramine O stain for mycobacteria
238) Chlamydia trachomatis nucleic acid testing
239) Trypanosoma cruzi in a Giemsa-stained blood smear; identification
240) Laboratory identification of Zygomycetes
241) Negri bodies; rabies infection
242) Naegleria fowleri; primary amoebic meningoencephalitis
243) Nocardia; beaded gram-positive bacilli, modified acid fast
244) Malassezia furfur; growth requirements, parenteral nutrition
245) Vibrio; thiosulfate citrate bile salts agar
246) Gram stain; reagent effects
247) Laboratory diagnosis of rotavirus
248) Granulicatella and Abiotrophia; growth characteristics
TRANSFUSION MEDICINE
2012
276) Composition of prothrombin complex concentrates
277) Organisms transmitted in red blood cell transfusions
278) Donath-Landsteiner antibodies; C3d + DAT, do not interfere with routine testing
279) Rh immune globulin, anti-D; D positive patients with immune thrombocytopenic purpura (ITP)
280) Regulatory requirement for transfusion committee
281) HLA loci (A, B, C, DR) matching; successful outcome in stem cell transplantation
282) Use of Rh immune globulin (RhIg) when giving Rh positive platelets to a Rh negative patient
283) Cryoprecipitated AHF; factor and fibrinogen contents
284) The FDA requires next day reporting death of a patient from a complication of transfusion
285) Differentiating transfusion associated circulatory overload and transfusion-related acute lung injury
286) Antibody to low incidence antigens
287) Specific gravity of the various cells in blood
288) Antibody panel red cells; are blood group
289) Jehovahs Witness patients; acceptable transfusion products
290) Infectious disease screening of blood donors
291) Mothers genotype; homozygous for HPA1b
292) Storage of hematopoietic stem cells
293) Cirrhotic patients; interpreting coagulation studies
299)
300)
301)
302)
303)
304)
305)
306)
307)
308)
309)
310)
311)
312)
313)
314)
2015
272) Iron overload from chronic red cell transfusions
273) Causes of transfusion related mortality and transfusion reactions
274) Blood transfusion support for solid organ transplants
275) History of viral hepatitis; deferral status
276) Therapeutic plasma exchange in hyperviscosity syndrome
277) Determine platelet transfusion response; body surface area, corrected count increment (CCI)
278) ABO typing discrepancies caused by rouleaux
279) Hemoglobin electrophoresis and associated clinical disorders
280) Principal cause of transfusion-related acute lung injury (TRALI)
281) Advantages and adverse reactions from autologous blood
282) HLA and clinical presentations: HFE, B27, DQ6
283) Hemolysis in ABO mismatched hematopoietic progenitor cell transplantation
284) ABO typing using tube methodology
285) Indications for use of intravenous immune globulin
286) Blood bank modifications of platelets for neonatal alloimmune thrombocytopenia (NAITP)
287) Red blood cell parasite disorders
288) Hematopoietic progenitor cell collection in pediatric patients
289) Antibody panel interpretation and associated antibody properties
290) Factor VIII is used for hemophilia A
291) Serologic findings in post-transfusion purpura
292) Investigation of a positive direct antiglobulin test with hemolysis
293) Effect of Rh type on Fresh Frozen Plasma transfusion
294) Cryoprecipitated antihemophilic factor; factor and fibrinogen contents
295) Pathophysiology and laboratory testing in thrombotic thrombocytopenic purpura (TTP)
296) Audits of transfusions; appropriateness of blood component usage
297) Frequency of apheresis platelet donation
298) AABB minimal requirements for granulocytes dose
HEMATOPATHOLOGY
.
2012
315) Systemic mastocytosis involving bone marrow
316) Cat scratch disease
317) Lymphoplasmacytic lymphoma
318) Mantle cell lymphoma; immunophenotype
319) Nasal T/NK lymphoma; necrosis
320) Phenotypic and histologic features of primary splenic marginal zone lymphoma
321) Changes in the bone marrow trabecula in patients with renal failure
322) Morphologic features of hyaline vascular Castleman disease
323) Myeloproliferative disease; leukoerythroblastic anemia
324) Myc /IgH translocation in Burkitt lymphoma
325) Bone marrow involvement by follicular lymphoma
326) Dermatopathic lymphadenopathy, late stage, associated with chronic dermatitis
327) Origin of Reed-Sternberg cells
328) Immunophenotype of most normal plasma cells
329) Nodular lymphocyte, predominant Hodgkin lymphoma; identification
2013
316) Lymph node follicular lymphoma; t(14;18) translocation
317) Mantle cell lymphoma versus chronic lymphocytic leukemia
318) Angioimmunoblastic T-cell Lymphoma
319) Mantle cell lymphoma; immunophenotype
320) Hairy cell leukemia; flow cytometric immunophenotyping
321) Nasal T/NK lymphoma; necrosis
322) Megakaryocyte morphology in myelodysplastic syndromes (MDS) with isolated del(5q)
323) Chronic idiopathic myelofibrosis; characteristics
324) Monoclonal gammopathy of undetermined significance; multiple myeloma
325) Mycosis fungoides
326) Nodular sclerosis classical Hodgkin lymphoma; abnormal B-cell program, expresses PAX5
327) Mast cell disease can be associated with a non-mast cell hematopoietic malignancy
328) HIV and Parvovirus
329) Nodular lymphocyte, predominant Hodgkin lymphoma; identification
330) Castleman disease; clinical and morphologic features
2014
315)
316)
317)
318)
319)
320)
321)
322)
323)
324)
325)
326)
327)
328)
2015
312) Nodular lymphocyte, predominant Hodgkin lymphoma; identification
313) International Prognostic Scoring Index; myelodysplastic syndromes
314) Mantle cell lymphoma; immunophenotype
315) Reactive lymphoid hyperplasia, follicular type
316) Anaplastic large cell lymphoma
317) Lymph node biopsy; classical Hodgkin lymphoma - immunophenotype
318) Myeloproliferative disorder with JAK-2 mutation
319) Kimura disease; benign chronic inflammatory disease in the head and neck region
320) Features of lymphoplasmacytic lymphoma
321) Extramedullary hematopoiesis in splenic red pulp
322) Essential thrombocythemia; normocellular marrow
323) Nasal T/NK lymphoma; necrosis
324) Features of poor fixation in a bone marrow specimen
325) Toxoplasma lymphadenitis
326) Myeloid sarcoma cells; myeloperoxidase
LABORATORY ADMINISTRATION
2012
330) Regulating agencies for biohazardous materials
331) Laboratory information system; validation
332) Define benchmarking
333) Federal regulatory; referral to diagnostic facility in which there is a financial interest
334) The AP post-analytic phase includes the issuance of a complete surgical pathology report
335) Root cause analysis helps to identify the primary cause and contributing factors to a sentinel event
336) Root cause analysis; retrospective process
337) Quality control record; retention time
338) Computer interfaces
339) Goals of laboratory automation of pre-analytic processing
340) How pixel color information is stored
341) SWOT analysis; applications
342) Definition of management
343) Digital pathology
344) Measure of precision; coefficient of variation
345) Logical observation identifiers, names and codes (LOINC); purpose
346) Proficiency testing
347) Blood products; large expense item
2013
331) Criterion based job description
332) Error classification; anatomic pathology
333) Interface engines; purposes
334) Elements required to establish medical malpractice
335) Diagnosis codes for billing
336) Instruments performing same analyte; comparison and quality control
337) Productivity; measure of outputs per input resources
338) Sentinel event definition
339) Federal law describing rules for administration of salaries and wages
340) Failure mode effects analysis; evaluation of pre-analytic system changes
341) HIPAA compliance; release of personal health information
342) HL7; common standard used for system interfaces
343) Pre-analysis steps in automation
344) Material safety data sheets; information provided
345) Occupation Safety and Health Administration; bloodborne pathogen standard
346) Logical observation identifiers, names and codes (LOINC); purpose
347) Privileged communications and medical records
348) Quality improvement models
349) College of American Pathologists Phase II deficiency
350) Accounts receivables
351) Blood products; large expense item
2014
329)
330)
331)
332)
333)
334)
335)
336)
337)
338)
339)
340)
341)
342)
343)
344)
345)
346)
347)
348)
2015
327) Appointment process; privileges granted to hospital medical staff
328) Pareto Principle applied to quality control in the laboratory
329) Formula for return on investment when looking at new technologies
330) Six Sigma; quality management tool
331) Understand principles of document management
332) Developing a strategic plan
333) Blood products; large expense item
334) Understanding the core competencies as developed by ABMS and ACGME
335) Branding and brand differentiation
336) 5S technique
337) Logical observation identifiers, names and codes (LOINC); purpose
338) Proficiency testing; failures and criteria to resume testing
339) Understanding allowable interview questions
340) Deleted
341) Understanding provisions set forth in HIPAA
342) Statistical tools for result validation
343) Criteria for malpractice
344) Test utilization management tools
MOLECULAR PATHOLOGY
2012
348) Cytogenetic alteration in Turner syndrome
349) Molecular markers to assess bone marrow engraftment
350) Isothermal amplification for transcription mediated amplification and nucleic acid sequence based
amplification
351) FISH probe design, Ewings sarcoma
352) Current status of DNA sequencing
353) Cytogenetic alterations in Prader-Willi and Angelman syndromes
Patenting genes
Chemistry used by next generation sequencing
Composition of nucleosome
Variation in hepatitis C treatment
Isothermal amplification for transcription mediated amplification and nucleic acid sequence based
amplification
Dominant gene expressed in hetero and homozygous states
Burkitt lymphoma translocations dysregulate C-MYC
Inappropriate bands in control sample
357)
358)
359)
360)
361)
362)
363)
364)
365)
366)
2015
345) Dominant gene expressed in hetero and homozygous states
346) Comparative genome hybridization
347) Risk analysis of autosomal recessive inheritance
348) Prader-Willi syndrome
349) HIV viral load testing by reverse transcription polymerase chain reaction amplification
350) FISH genotype; hemizygosity for ELN
351) Metabolism of drugs by cytochrome p450
352) Chromosome analysis, karyotype of metaphase spread; deletion
353) DNA quality in formalin fixed tissue
354) Karyotype of partial molar pregnancy
355) Interpretation of paternity tests
356) Consequences of a HIPAA violation
357) Chemistry used by next generation sequencing
358) Likelihood of HLA identical genotype in siblings
359) Heavy chain CDR3 length; V, D, and J segments
360) Understanding the effect different mutations have on the function of a protein
361) Isothermal amplification for transcription mediated amplification and nucleic acid sequence based
amplification
362) Karyotype; chronic myelogenous leukemia (CML)